Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy. | J Immunother Cancer | 2024 | 38242718 | PubTator, text mining | PubMed |
| Folate receptor overexpression induces toxicity in a diet-dependent manner in C. elegans. | Sci Rep | 2024 | 38212621 | PubTator, text mining | PubMed |
| Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy. | Cell Rep Med | 2024 | 38194971 | PubTator, text mining | PubMed |
| Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities. | Cell Genom | 2024 | 38190106 | PubTator, text mining | PubMed |
| Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks. | J Exp Clin Cancer Res | 2024 | 38183103 | PubTator, text mining | PubMed |
| [Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract. German version]. | Pathologie (Heidelb) | 2024 | 38170268 | PubTator, text mining | PubMed |
| Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop. | Oncogene | 2024 | 37935976 | PubTator, text mining | PubMed |
| LncRNA KTN1-AS1 facilitates esophageal squamous cell carcinoma progression via miR-885-5p/STRN3 axis. | Genes Genomics | 2024 | 37747640 | PubTator, text mining | PubMed |
| Overall Survival, BRAF, RAS, and MSI Status in Patients Who Underwent Cetuximab After Refractory Chemotherapy for Metastatic Colorectal Cancer. | J Gastrointest Cancer | 2024 | 37608030 | PubTator, text mining | PubMed |
| [A Case of Advanced Recurrent Rectal Cancer Successfully Treated by Rechallenge Therapy with an Anti-Epidermal Growth Factor Receptor(EGFR)Drug]. | Gan To Kagaku Ryoho | 2023 | 38303322 | PubTator, text mining | PubMed |
| Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. | bioRxiv | 2023 | 38234720 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Key Regulators in Lung Cancer. | Int J Mol Sci | 2023 | 38203731 | PubTator, text mining | PubMed |
| A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer. | J Clin Med | 2023 | 38202064 | PubTator, text mining | PubMed |
| Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer. | Cancers (Basel) | 2023 | 38201569 | PubTator, text mining | PubMed |
| Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer. | Sci Rep | 2023 | 38071230 | PubTator, text mining | PubMed |
| [Ⅱ. MSI-High and dMMR Resectable Colorectal Cancer(Colon Cancer and/or Rectal Cancer)-Current Status and Prospects for Preoperative Treatment]. | Gan To Kagaku Ryoho | 2023 | 38056868 | PubTator, text mining | PubMed |
| Ropivacaine inhibits the malignant behavior of lung cancer cells by regulating retinoblastoma-binding protein 4. | PeerJ | 2023 | 38034873 | PubTator, text mining | PubMed |
| Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research. | Front Mol Biosci | 2023 | 38028543 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer. | Front Oncol | 2023 | 38023196 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development. | Int J Mol Sci | 2023 | 38003512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=13